Trials / Terminated
TerminatedNCT04147143
CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-interventional study to retrospectively evaluate the safety and to describe the effectiveness of cabozantinib after immunoncologic treatment with nivolumab or nivolumab plus ipilimumab in routine clinical practice. It consists of a retrospective chart review of patients who have already completed treatment with cabozantinib after nivolumab or nivolumab plus ipilimumab before inclusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Documentation | Retrospective chart review of patients who have already completed treatment with cabozantinib after nivolumab or nivolumab plus ipilimumab before inclusion. |
Timeline
- Start date
- 2019-03-08
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2019-10-31
- Last updated
- 2022-12-23
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04147143. Inclusion in this directory is not an endorsement.